Optimizerx Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OptimizeRx Corporation (OPRX) on June 24, 2025, covering events occurring on June 20, 2025. The company is incorporated in Nevada and trades on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Board Expansion: Effective June 20, 2025, the Board of Directors increased its size to six (6) members.
- Director Appointment: Stephen Silvestro, the Company's CEO, was appointed as a director. His term extends until the 2026 annual meeting of stockholders or until his successor is elected and qualified, subject to earlier death, resignation, or removal.
Guidance, Outlook, and Risks
The filing references a press release issued on June 24, 2025, regarding the Board changes (Exhibit 99.1). No financial guidance, outlook, management commentary on operations, or specific risk factors were disclosed in this document.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for additional context on the Board expansion.
- Confirm the current composition of the Board of Directors on the company's investor relations website.
- Review the company's most recent 10-Q or 10-K for financial metrics, as this 8-K contains no financial data.